ARTIST: ARThrose Intervention STandardisée

This study has been completed.
Sponsor:
Information provided by:
Almirall, SAS
ClinicalTrials.gov Identifier:
NCT00462319
First received: April 18, 2007
Last updated: NA
Last verified: April 2007
History: No changes posted
  Purpose

International recommendations (ACR,EULAR) emphasize physical exercise and weight loss for patients suffering from knee osteoarthritis. Nevertheless, number of patients receiving advices for these 2 points still low. This study evaluates the impact of a standardized medical intervention (patient education, weight reduction and physical exercise) in knee osteoarthritis patients.


Condition Intervention Phase
Knee Osteoarthritis
Behavioral: Education, weight reduction and physical exercise
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Evaluation of Standardized Management of Knee Arthritis Patients

Resource links provided by NLM:


Further study details as provided by Almirall, SAS:

Primary Outcome Measures:
  • Weight
  • Physical Exercise in Leisure

Study Start Date: May 2005
  Eligibility

Ages Eligible for Study:   45 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • symptomatic and ambulatory patients
  • suffering from knee osteoarthritis (ACR criteria)
  • 25<BMI<35
  • signed informed consent

Exclusion Criteria:

  • need to surgery within 6 next months
  • co-morbidity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00462319

Locations
France
Paris, France
Sponsors and Collaborators
Almirall, SAS
Investigators
Principal Investigator: René Marc FLIPO Hôpital Salengro - Lille, France
  More Information